These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The epidemiology of amyotrophic lateral sclerosis (ALS/MND) in people aged 80 or over. Forbes RB; Colville S; Swingler RJ; Age Ageing; 2004 Mar; 33(2):131-4. PubMed ID: 14960427 [TBL] [Abstract][Full Text] [Related]
3. Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register. Forbes RB; Colville S; Swingler RJ; J Neurol; 2004 Jul; 251(7):813-7. PubMed ID: 15258782 [TBL] [Abstract][Full Text] [Related]
4. Identifying who will benefit from non-invasive ventilation in amyotrophic lateral sclerosis/motor neurone disease in a clinical cohort. Berlowitz DJ; Howard ME; Fiore JF; Vander Hoorn S; O'Donoghue FJ; Westlake J; Smith A; Beer F; Mathers S; Talman P J Neurol Neurosurg Psychiatry; 2016 Mar; 87(3):280-6. PubMed ID: 25857659 [TBL] [Abstract][Full Text] [Related]
5. Improved survival and 30-day mortality after gastrostomy in Scottish motor neurone disease patients: evidence from a national retrospective cohort study using STROBE criteria. Gorrie GH; Chandran S; Colville S; Newton J; Leighton D; Mcdonald M; Pal S; Forbes R; Hair M; Swingler R Amyotroph Lateral Scler Frontotemporal Degener; 2019 May; 20(3-4):165-171. PubMed ID: 30835562 [No Abstract] [Full Text] [Related]
6. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Miller RG; Mitchell JD; Lyon M; Moore DH Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806 [TBL] [Abstract][Full Text] [Related]
7. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy. Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G; Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545 [TBL] [Abstract][Full Text] [Related]
8. Cause of death and clinical grading criteria in a cohort of amyotrophic lateral sclerosis cases undergoing autopsy from the Scottish Motor Neurone Disease Register. Kurian KM; Forbes RB; Colville S; Swingler RJ J Neurol Neurosurg Psychiatry; 2009 Jan; 80(1):84-7. PubMed ID: 19091712 [TBL] [Abstract][Full Text] [Related]
9. Motor axonal excitability properties are strong predictors for survival in amyotrophic lateral sclerosis. Kanai K; Shibuya K; Sato Y; Misawa S; Nasu S; Sekiguchi Y; Mitsuma S; Isose S; Fujimaki Y; Ohmori S; Koga S; Kuwabara S J Neurol Neurosurg Psychiatry; 2012 Jul; 83(7):734-8. PubMed ID: 22566594 [TBL] [Abstract][Full Text] [Related]
10. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study. Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G; J Neurol Neurosurg Psychiatry; 2008 Jan; 79(1):33-7. PubMed ID: 17550991 [TBL] [Abstract][Full Text] [Related]
11. Is firstly diagnosed ALS really ALS? Results of a population-based study with long-term follow-up. Pupillo E; Bianchi E; Poloni M; Beghi E; Amyotroph Lateral Scler Frontotemporal Degener; 2017 May; 18(3-4):221-226. PubMed ID: 27892707 [TBL] [Abstract][Full Text] [Related]
12. The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ventilation. Lo Coco D; Marchese S; La Bella V; Piccoli T; Lo Coco A Chest; 2007 Jul; 132(1):64-9. PubMed ID: 17475635 [TBL] [Abstract][Full Text] [Related]
13. Slower disease progression and prolonged survival in contemporary patients with amyotrophic lateral sclerosis: is the natural history of amyotrophic lateral sclerosis changing? Czaplinski A; Yen AA; Simpson EP; Appel SH Arch Neurol; 2006 Aug; 63(8):1139-43. PubMed ID: 16908741 [TBL] [Abstract][Full Text] [Related]
14. Survival of patients with amyotrophic lateral sclerosis in a population-based registry. Millul A; Beghi E; Logroscino G; Micheli A; Vitelli E; Zardi A Neuroepidemiology; 2005; 25(3):114-9. PubMed ID: 15956808 [TBL] [Abstract][Full Text] [Related]
15. The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: a population based study in Modena, Italy. Georgoulopoulou E; Fini N; Vinceti M; Monelli M; Vacondio P; Bianconi G; Sola P; Nichelli P; Mandrioli J Amyotroph Lateral Scler Frontotemporal Degener; 2013 Sep; 14(5-6):338-45. PubMed ID: 23373475 [TBL] [Abstract][Full Text] [Related]
16. [Survival in amyotrophic lateral sclerosis]. Alcaz S; Jarebinski M; Pekmezović T; Marinković Z; Apostolski S Srp Arh Celok Lek; 1997; 125(1-2):19-23. PubMed ID: 17974351 [TBL] [Abstract][Full Text] [Related]
17. Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study. Luna J; Diagana M; Ait Aissa L; Tazir M; Ali Pacha L; Kacem I; Gouider R; Henning F; Basse A; Cisse O; Balogou AAK; Kombate D; Agbetou M; Houinato D; Millogo A; Agba T; Belo M; Penoty M; Raymondeau-Moustafa M; Hamidou B; Couratier P; Preux PM; Marin B; J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):20-29. PubMed ID: 30242088 [TBL] [Abstract][Full Text] [Related]